Por favor, use este identificador para citar o enlazar este ítem:
http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2156| Título : | Changes in acetylator phenotype over the lifespan in the Wistar rat |
| Creador: | Lares Asseff I |
| Nivel de acceso: | Open access |
| Palabras clave : | Acetilación - Ratas Efectos de envejecimiento - drogas - Ratas Envejecimiento - metabolismo - Ratas Estudios longitudinales - Ratas fenotipo - Ratas Ratas Wistar - Ratas Sulfadiazina - administración y dosificación - Ratas Sulfadiazina - metabolismo - Ratas Factores de tiempo - Ratas Acetylation - Rats Aging - drug effects - Rats Aging - metabolism - Rats Longitudinal Studies - Rats Phenotype - Rats Rats, Wistar - Rats Sulfadiazine - administration & dosage - Rats Sulfadiazine - metabolism - Rats Time Factors - Rats Metabolismo Años Rata fenotipo de acetilación Metabolism Age Rat Acetylator phenotype |
| Descripción : | Acetylation capacity during drug metabolism differs between species, gender and age groups. Objective: The purpose of this work was to determine variations in the acetylating phenotype (AP), in a longitudinal study, as a function of growth and development. Methods: Twenty male Wistar rats were studied. AP was determined on days 21, 48, 114, 180, 457 and 780 with oral doses of 30 mg/kg of sulphadiazine (SDZ) by urine collection. The Schröeder and Vree methods were used to obtain SDZ concentrations, both acetylated and not acetylated. Rats were classified as slow or fast acetylators in accordance with previously validated metabolic indicators. Results: Of the 20 rats phenotyped at 21 and 48 days of age, 18 were slow and 2 were fast acetylators. As age and consequent growth progressed, changes in the expression of AP were registered. At 114 days, 16 rats were slow and 4 were fast acetylators; at 180 days, 12 were slow and 8 were fast; at 457 days, 6 were slow and 14 were fast; at 780 days, the 20 rats were fast acetylators. Slow acetylation predominates at younger ages. Conclusions: The effect of growth and developmental progress on AP is evident and relates to previous reports of changes in AP, determined by age in animal and human models. The relevance of changes determined by growth and development should be considered in rational drug management. © 2005 Elsevier Ireland Ltd. All rights reserved. |
| Colaborador(es) u otros Autores: | Camacho GA Guillé AJ Toledo AR Trujillo F Reyes RE Juárez HM Pérez G |
| Fecha de publicación : | 2006 |
| Tipo de publicación: | Artículo |
| Formato: | |
| Identificador del Recurso : | 10.1016/j.mad.2005.09.009 |
| Fuente: | Mechanisms of Ageing and Development 127(1):73 - 78 |
| URI : | http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2156 |
| Idioma: | eng |
| Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.